GPT and metabolic dysfunction-associated steatohepatitis: However, as the disease progresses to MASH, hepatic inflammation and hepatocyte damage gradually appear, leading to potentially significant increases in ALT and AST levels.27, 28, 29 Recent studies demonstrated that tirzepatide significantly lowered ALT and AST levels, suggesting its potential to alleviate liver damage.14